JANIS FREEMAN: Open Payments
NPI 1730493214 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 27 payments from 9 companies in 2025. Trend: 2023 $656 · 2024 $747 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $149 |
| ABBVIE INC. | 5 | $87 |
| PFIZER INC. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lilly USA, LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $41 |
| Amgen Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: ELIQUIS, REXULTI, Ozempic, AIRSUPRA, Wegovy, VRAYLAR, UBRELVY, QULIPTA.
Industry payments across NY — which companies pay providers there.
